The injection is given just under the skin, similar to insulin injections that diabetics use daily
Results showed that Melanotan II administration increased insulin-mediated glucose disposal, but didnt affect the capacity of insulin to suppress EGP
These medications are contraindicated per the FDA boxed warning when there is a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
Additionally, Epac2, a cAMP-regulated exchange protein, activates ras-proximate-1 (Rap1), thereby enhancing phospholipase C (PLC) signaling-dependent calcium release [15]
Patients with a history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, pancreatitis, or severe gastrointestinal conditions should consult with their provider for suitable alternatives
This will help minimise the risk of injection site reactions and infections